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Impact Of Preoperative Hemoglobina1c In Patients
Undergoing Open Distal Vascular Procedures

Renal Recovery In Patients With Type B Aortic
Dissections Who Underwent Aortic Stent Placement: A
Retrospective Review

Abdul Kader Natour,1 Alexander D. Shepard,1 Mitchell Weaver,1
Timothy Nypaver,1 Peter Henke,2 Loay Kabbani1. 1Henry Ford Health
System, Detroit, MI; 2University of Michigan Health, Ann Arbor, MI
Objective: The purpose of this study was to evaluate if preoperative hemoglobin (Hb) A1c levels was associated with worse outcomes in patients
undergoing open lower extremity (LE) revascularization.
Methods: A retrospective review of a statewide vascular surgery registry
was queried for all patients who underwent open infrainguinal bypass or
open LE thrombectomy procedures between January 2014 and June
2021. Patients were categorized into four groups depending on whether
their plasma HbA1c was #6%, >6% to #8%, >8% to #10%, and >10%.
Regression models were used to evaluate the association between preoperative HbA1c and postoperative major adverse limb events (MALE),
major adverse cardiac events (MACE), mortality, and length of stay (LOS).
Results: A total of 5388 patients were included in the study. The
average age was 66 years. Sixty-six percent of the cohort were male,
and 78% were white. Demographics and comorbidities were associated
with the HbA1c level. Mean LOS was 7 days for HbA1c <6% and 10 days
for HbA1c >10% (P < .001). No signiﬁcant association was found when
looking at perioperative MALE, MACE, 30-day mortality, or 1-year mortality. On multivariate analysis, only LOS remained signiﬁcantly associated
with the level of HbA1c (P < .001) (Table).
Conclusions: Suboptimal preoperative glycemic control in patients undergoing open LE vascular procedures for ischemia is associated with an
increased risk of LOS. HbA1c level was not predictive of worse perioperative MACE, MALE, or mortality in this cohort. The increased in LOS could
be explained by unmeasured complications, frailty, or increased hospitalization time needed to optimize glycemic control before discharge.
Table. Multivariate analyses for length of stay, perioperative major
adverse limb events (MALE), perioperative major adverse cardiace
events (MACE), and 30-day mortality based on preoperative hemoglobin (Hb) A1c level
Predictors

OR

95% CI

P

Postoperative MACE
HbA1c <6%

1

HbA1c >6% to #8%

1.18

0.90-1.56

.23

HbA1c >8% to #10%

1.01

0.69-1.48

.97

0.84

0.50-1.40

.49

OR

95% CI

P

HbA1c >10%
Post-operative MALE
HbA1c <6%
HbA1c >6% to #8%

Jake Nicholson,1 Christina Maria Supino,2 Eanas Yassa2. 1Vascular
Surgery, Spectrum Health/ Michigan State University, Grand Rapids,
MI; 2Spectrum Health/Michigan State University, Grand Rapids, MI
Objective: The objective of this study was to demonstrate intervening
in the subacute period of type B aortic dissection for indications of renal
failure/insufﬁciency is a safe and effective treatment.
Methods: This is a single-center retrospective review of 46 patients who
received treatment for descending thoracic aortic pathology including
both dissections and aneurysms from 2016 to 2022. Of those patients,
seven were found to have acute renal insufﬁciency or failure as one of
the indications for endovascular aortic intervention. Patient demographics are noted in Table I. The creatinine and glomerular ﬁltration
rate for these patients were trended from the time of dissection until
initial renal recovery and return to baseline or new baseline. The seven patients were classiﬁed into four categories based on their time to intervention from initial presentation: hyperacute, acute, subacute, and chronic
according to the Society for Vascular Surgery/Society of Thoracic Surgeons (SVS/STS) guidelines.
Results: Of the seven patients, one had an intervention in the hyperacute, three in the acute, two in the subacute, and one in the chronic
period. Acute renal failure was an indication for intervention in ﬁve of
the patients, and renal insufﬁciency was an indication in the other two.
Complete renal recovery to baseline was achieved in four of seven patients. Renal recovery to a new lower baseline was achieved in two of
seven patients. One patient became dialysis-dependent. Covered stent
grafts were used in six of seven patients. A dissection endovascular stent
was used in all seven patients. Further characterization of renal recovery is
summarized in Table II.
Conclusions: Intervening in the subacute period with evidence of renal
malperfusion is a safe and effective strategy for repair. All patients in the
subacute treatment group experienced renal recovery back to baseline
and at a faster rate than intervention in either the hyperacute or acute
groups. Treatment in the subacute period is recommended for patients
with acute type B dissection and renal injury if no other indication warrants more urgent intervention. Subacute intervention reduces the risks
associated with the highly dynamic pathology of renal insufﬁciency after
dissection and produces similar if not better outcomes in the treatment

Table I. Demographics
No. patients

1

Age 50-70 years

1.23

.35

Age >70 years

1
4
3

0.79-1.90

HbA1c >8% to #10%

1.75

1.03-3.00

.04

Male

HbA1c >10%

1.40

0.74-2.65

.30

Female

Total LOS

IRR

HbA1c <6%

1

HbA1c >6% to #8%

1.21

HbA1c >8% to #10%

1.26

95% CI

1.18-1.24
1.22-1.30

Tobacco history

3

Hypertension

7

<.01

Chronic kidney disease

0

<.01

Diabetes

1

Vascular disease

1

P

HbA1c >10%

1.20

1.15-1.24

<.01

30-day mortality

OR

95% CI

P

HbA1c <6%

6

1

HbA1c >6% to #8%

0.91

0.59-1.41

.69

HbA1c >8% to #10%

0.91

0.50-1.64

.75

HbA1c >10%

0.72

0.32-1.61

.43

CI, Conﬁdence interval; IRR, incidence rate ratio; OR, odds ratio.
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Table II. Comparison of renal recovery across all groups
Rate of com- Average time to Average time to complete renal initial renal recov- plete/partial renal recovrecovery
ery, days
ery, days
Hyperacute

1/1

9

14

Acute

0/3

1

10.5

Subacute

2/2

0

2

Chronic

1/1

0

1
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